Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-22-038446

Director acquired 12,006 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Chrousos Phaedra Director 2022-06-16 Grant or award +12,006 24,931 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Chrousos Phaedra Director 2022-06-16 Grant or award · Stock Option (Right to Buy) +24,707 24,707 D: show line 2 in the form
Loading xslF345X03/doc4.xml…